Arenas J, Martín M A
Laboratorio de enfermedades mitocondriales y nurometabólicas, Centro de Investigación Hospital Universitario 12 de Octubre, Madrid, Spain.
Neurologia. 2003 Jul-Aug;18(6):291-302.
Exercise intolerance (EI) is a frequent cause of medical attention, although it is sometimes difficult to come to a final diagnosis. However, there is a group of patients in whom EI is due to a metabolic dysfunction. McArdle's disease (type V glucogenosis) is due to myophosphorylase (MPL) deficiency. The ischemic exercise test shows a flat lactate curve. The most frequent mutations in the PYGM gene (MPL gene) in Spanish patients with MPL deficiency are R49X and W797R. Carnitine palmitoyltransferase (CPT) II deficiency is invariably associated to repetitive episodes of myoglobinuria triggered by exercise, cold, fever or fasting. The diagnosis depends on the demonstration of CPT II deficiency in muscle. The most frequent mutation in the CPT2 gene is the S113L. Patients with muscle adenylate deaminase deficiency usually show either a mild myopathy or no symptom. The diagnosis is based on the absence of enzyme activity in muscle and the lack of rise of ammonia in the forearm ischemic exercise test. The mutation Q12X in the AMPD1 gene is strongly associated with the disease. Exercise intolerance is a common complaint in patients with mitochondrial respiratory chain (MRC) deficiencies, although it is often overshadowed by other symptoms and signs. Only recently we have come to appreciate that exercise intolerance can be the sole presentation of defects in the mtDNA, particularly in complex I, complex III, complex IV, or in some tRNAs. In addition, myoglobinuria can be observed in patients under statin treatment, particularly if associated with fibrates, due to an alteration in the assembly of the complex IV of the MRC.
运动不耐受(EI)是就医的常见原因,尽管有时难以做出最终诊断。然而,有一组患者的EI是由代谢功能障碍引起的。麦克尔氏病(Ⅴ型糖原贮积病)是由于肌磷酸化酶(MPL)缺乏所致。缺血运动试验显示乳酸曲线平坦。西班牙MPL缺乏患者中PYGM基因(MPL基因)最常见的突变是R49X和W797R。肉碱棕榈酰转移酶(CPT)Ⅱ缺乏总是与运动、寒冷、发热或禁食引发的反复肌红蛋白尿发作相关。诊断取决于肌肉中CPTⅡ缺乏的证实。CPT2基因最常见的突变是S113L。肌肉腺苷酸脱氨酶缺乏的患者通常表现为轻度肌病或无症状。诊断基于肌肉中酶活性的缺乏以及前臂缺血运动试验中氨不升高。AMPD1基因中的Q12X突变与该疾病密切相关。运动不耐受是线粒体呼吸链(MRC)缺乏患者的常见主诉,尽管它常常被其他症状和体征所掩盖。直到最近我们才认识到运动不耐受可能是mtDNA缺陷的唯一表现,特别是在复合体Ⅰ、复合体Ⅲ、复合体Ⅳ或某些tRNA中。此外,他汀类药物治疗的患者可出现肌红蛋白尿,特别是与贝特类药物联用时,这是由于MRC复合体Ⅳ组装改变所致。